PROVENGE® (sipuleucel-T) for Metastatic Castration-Resistant Prostate Cancer - Cancer Therapy Advisor

PROVENGE® (sipuleucel-T) for Metastatic Castration-Resistant Prostate Cancer

Slideshow

  • provenge-sipuleucel-t-drug-showcase-prostate-cance

  • provenge-sipuleucel-t-drug-showcase-prostate-cance

  • provenge-sipuleucel-t-drug-showcase-prostate-cance

  • provenge-sipuleucel-t-drug-showcase-prostate-cance

  • provenge-sipuleucel-t-drug-showcase-prostate-cance

  • provenge-sipuleucel-t-drug-showcase-prostate-cance

  • provenge-sipuleucel-t-drug-showcase-prostate-cance

  • provenge-sipuleucel-t-drug-showcase-prostate-cance

  • provenge-sipuleucel-t-drug-showcase-prostate-cance

  • provenge-sipuleucel-t-drug-showcase-prostate-cance

  • provenge-sipuleucel-t-drug-showcase-prostate-cance

  • provenge-sipuleucel-t-drug-showcase-prostate-cance

  • provenge-sipuleucel-t-drug-showcase-prostate-cance

  • provenge-sipuleucel-t-drug-showcase-prostate-cance

  • provenge-sipuleucel-t-drug-showcase-prostate-cance

  • provenge-sipuleucel-t-drug-showcase-prostate-cance

  • provenge-sipuleucel-t-drug-showcase-prostate-cance

  • provenge-sipuleucel-t-drug-showcase-prostate-cance

  • provenge-sipuleucel-t-drug-showcase-prostate-cance

  • provenge-sipuleucel-t-drug-showcase-prostate-cance

  • provenge-sipuleucel-t-drug-showcase-prostate-cance

  • provenge-sipuleucel-t-drug-showcase-prostate-cance

  • provenge-sipuleucel-t-drug-showcase-prostate-cance

This slideshow reviews drug information for PROVENGE® (sipuleucel-T), indicated for metastatic castration-resistant prostate cancer (mCRPC).

Table of Contents

Slide 3: Indication, Dosage, and Administration
Slide 6: Use in Specific Populations
Slide 8: Clinical Pharmacology
Slide 12: Warnings and Precautions
Slide 15: Clinical Safety and Efficacy
Slide 21: Drug Storage and SupplySlide 23: References

Next hm-slideshow in Slides